会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 86. 发明授权
    • Potentiometric titration method for measuring concentration of acid mixture of aluminum etchant
    • 用于测量铝蚀刻剂酸混合物浓度的电位滴定法
    • US08945934B2
    • 2015-02-03
    • US13699638
    • 2012-08-23
    • Rui XuWeiwei ZhangJingming WuHonghui ZhuLi WangXiaobo HeHongqing Huang
    • Rui XuWeiwei ZhangJingming WuHonghui ZhuLi WangXiaobo HeHongqing Huang
    • G01N31/16G01N31/00
    • G01N31/164Y10T436/15
    • The present invention provides a potentiometric titration method for measuring concentration of acid mixture of aluminum etchant, which prepares identified potassium hydroxide-ethanol solution or sodium hydroxide-ethanol solution as a titrant and uses a monohydric alcohol and a diol as an anhydrous medium for the acid mixture of aluminum etchant to carry out titration of the acid mixture of aluminum etchant so as to realize measurement of concentration of each acid contained in the acid mixture of aluminum etchant through a one-stage process of potentiometric titration thereby reducing the complication of operation of inspection and uncertainty of inspection result and achieving the purposes of carrying out inspections with high precision and high performance. The method can efficiently and accurately measure the concentrations of nitric acid, phosphoric acid, and acetic acid contained in the acid mixture of aluminum etchant.
    • 本发明提供了一种电位滴定法,用于测量铝蚀刻剂的酸混合物的浓度,其制备鉴定的氢氧化钾 - 乙醇溶液或氢氧化钠 - 乙醇溶液作为滴定剂,并使用一元醇和二醇作为酸的无水介质 铝蚀刻剂的混合物进行铝蚀刻剂的酸混合物的滴定,以通过电位滴定的一步法来实现铝蚀刻剂的酸混合物中所含的每种酸的浓度的测量,从而减少检查操作的复杂性 检验结果不确定,达到高精度,高性能检测的目的。 该方法可以有效和准确地测量铝蚀刻剂酸性混合物中所含的硝酸,磷酸和乙酸的浓度。
    • 90. 发明授权
    • Regulatory T cell mediator proteins and uses thereof
    • 调节性T细胞介质蛋白及其用途
    • US08501915B2
    • 2013-08-06
    • US13546098
    • 2012-07-11
    • Randolph J. NoelleLi Wang
    • Randolph J. NoelleLi Wang
    • C07K16/00
    • C07K16/2827A61K38/00A61K2039/505C07K14/70596C07K2319/00C07K2319/30G01N33/505Y02A50/412Y02A50/423
    • The present invention relates to novel regulatory T cell proteins. One protein, designated PD-L3, resembles members of the PD-L1 family, and co-stimulates αCD3 proliferation of T cells in vitro. A second, TNF-like, protein has also been identified as being upregulated upon αCD3/αGITR stimulation. This protein has been designated Treg-sTNF. Proteins, antibodies, activated T cells and methods for using the same are disclosed.In particular methods of using these proteins and compounds, preferably antibodies, which bind or modulate (agonize or antagonize) the activity of these proteins, as immune modulators and for the treatment of cancer, autoimmune disease, allergy, infection and inflammatory conditions, e.g. multiple sclerosis is disclosed.
    • 本发明涉及新型调节性T细胞蛋白。 称为PD-L3的一种蛋白质类似于PD-L1家族的成员,并且在体外共同刺激T细胞的αCD3增殖。 第二种TNF样蛋白也被鉴定为在αCD3/αGITR刺激下上调。 该蛋白质已被命名为Treg-sTNF。 公开了蛋白质,抗体,活化的T细胞及其使用方法。 特别是使用这些蛋白质和化合物(优选抗体)的方法,其结合或调节(激动或拮抗)这些蛋白质的活性,作为免疫调节剂和用于治疗癌症,自身免疫疾病,变态反应,感染和炎性病症,例如, 公开了多发性硬化。